Literature DB >> 32542162

Plasmablastic Lymphoma Found on Autopsy in a Post-Transplant Patient.

Syed H Abbas1,2, Geetika Goyal2, Mohammad A Noory1, Abraham Loo1.   

Abstract

Plasmablastic lymphoma (PBL) is an aggressive lymphoma often seen in immunodeficient patients. It can be a diagnostic challenge given its high-grade appearance and lack of staining for traditional B-cell markers. We present an interesting case of a 65-year-old African-American female who presented to the emergency department (ED) with complaints of progressively worsening weakness, fatigue, and dizziness for one month, and dark-colored urine for three days. The patient's medical history was remarkable for a renal and pancreatic transplant in 2008.
Copyright © 2020, Abbas et al.

Entities:  

Keywords:  plasmablastic lymphoma; transplant

Year:  2020        PMID: 32542162      PMCID: PMC7292721          DOI: 10.7759/cureus.8109

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

Review 1.  Plasmablastic lymphoma and related disorders.

Authors:  Eric D Hsi; Robert B Lorsbach; Falko Fend; Ahmet Dogan
Journal:  Am J Clin Pathol       Date:  2011-08       Impact factor: 2.493

2.  Plasmablastic lymphoma following transplantation.

Authors:  Michael J Van Vrancken; Latoya Keglovits; John Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

3.  Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.

Authors:  Sunita D Nasta; George M Carrum; Imran Shahab; Nicola A Hanania; Mark M Udden
Journal:  Leuk Lymphoma       Date:  2002-02

4.  IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.

Authors:  Alexandra Valera; Olga Balagué; Luis Colomo; Antonio Martínez; Jan Delabie; Lekidelu Taddesse-Heath; Elaine S Jaffe; Elías Campo
Journal:  Am J Surg Pathol       Date:  2010-11       Impact factor: 6.394

5.  Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.

Authors:  Hossein Khedmat; Saeed Taheri
Journal:  Hematol Oncol Stem Cell Ther       Date:  2011

6.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

7.  Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.

Authors:  Francisco Vega; Chung-Che Chang; Leonard J Medeiros; Mark M Udden; Jeong Hee Cho-Vega; Ching-Ching Lau; Chris J Finch; Regis A Vilchez; David McGregor; Jeffrey L Jorgensen
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

8.  Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.

Authors:  Julie Morscio; Daan Dierickx; Jan Nijs; Gregor Verhoef; Emilie Bittoun; Xanne Vanoeteren; Iwona Wlodarska; Xavier Sagaert; Thomas Tousseyn
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

9.  Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients.

Authors:  G Opelz; R Henderson
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

Review 10.  Current knowledge on HIV-associated Plasmablastic Lymphoma.

Authors:  Michele Bibas; Jorge J Castillo
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.